[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599658":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":38,"responsibleParty":111,"collaborators":18,"id":113,"slug":114,"hasResults":115,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":119,"eligibilityCriteria":120,"healthyVolunteers":115,"sex":121,"minAge":122,"maxAge":18,"enrollmentInfo":123,"targetDuration":18,"studyType":126,"phases":127,"briefSummary":129,"conditions":130,"keywords":18,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Resilience","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","Edra PRO",[13],"Device: Edra PRO",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","NO_INTERVENTION","Standard care",null,[20],{"type":21,"name":11,"description":22,"armGroupLabels":23,"otherNames":18},"DEVICE","Remote monitoring software",[9],[25],{"name":26,"affiliation":27,"role":28},"Antoine Yrondi, MD, PhD","University Hospital, Toulouse","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Emma Touré Cuq, PharmD","CONTACT","+33646396617","emma.tourecuq@resilience.care",{"name":36,"role":32,"phone":18,"phoneExt":18,"email":37},"Charles Ferté","charles.ferte@resilience.care",[39,54,65,76,87,100],{"facility":40,"status":41,"city":42,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"CHU Besançon","RECRUITING","Besançon","France","FR",{"type":46,"coordinates":47},"Point",[48,49],6.01815,47.24878,{"lat":49,"lon":48},[52],{"name":53,"role":32,"phone":18,"phoneExt":18,"email":18},"Emmanuel Haffen",{"facility":55,"status":41,"city":56,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"CHU Grenoble Alpes","Grenoble",{"type":46,"coordinates":58},[59,60],5.71479,45.17869,{"lat":60,"lon":59},[63],{"name":64,"role":32,"phone":18,"phoneExt":18,"email":18},"Mircea Polosan, Pr",{"facility":66,"status":41,"city":67,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"EPSM de VEndée","La Roche-sur-Yon",{"type":46,"coordinates":69},[70,71],-1.42757,46.66974,{"lat":71,"lon":70},[74],{"name":75,"role":32,"phone":18,"phoneExt":18,"email":18},"Anne Sauvaget, Dr",{"facility":77,"status":41,"city":78,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"CHU de Lille","Lille",{"type":46,"coordinates":80},[81,82],3.05512,50.63391,{"lat":82,"lon":81},[85],{"name":86,"role":32,"phone":18,"phoneExt":18,"email":18},"Ali Amad, Pr",{"facility":88,"status":41,"city":89,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"Cabinet Corinne MARIE","Lisieux",{"type":46,"coordinates":91},[92,93],0.22925,49.1466,{"lat":93,"lon":92},[96],{"name":97,"role":32,"phone":98,"phoneExt":18,"email":99},"Corinne MARIE, MD","+33632312570","corinne.marie0755@orange.fr",{"facility":101,"status":41,"city":102,"state":18,"zip":18,"country":43,"countryCode":44,"cosmosGeoPoint":103,"geoPoint":107,"contacts":108},"CHU de Toulouse","Toulouse",{"type":46,"coordinates":104},[105,106],1.44367,43.60426,{"lat":106,"lon":105},[109],{"name":110,"role":32,"phone":18,"phoneExt":18,"email":18},"Antoine Yrondi, Pr",{"type":112,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100599658","efficacy-of-remote-monitoring-in-patients-treated-for-moderate-to-severe-major-depressive-episodes-100599658",false,"NCT07087353","Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes","A Randomized Controlled Trial Assessing the Efficacy of Remote Patient Monitoring in Patients Treated for a Moderate to Severe Major Depressive Episode","EC-102","Inclusion Criteria:\n\n* Adults (≥18 years old) meeting ICD-11 criteria for a moderate to severe major depressive episode\n* Access to a personal smartphone and an internet connection, and cognitively able to use it independently\n\nExclusion Criteria:\n\n* Pregnant women\n* Individuals under legal guardianship or conservatorship\n* Ongoing alcohol or drug abuse considered likely to interfere with study participation, as judged by the investigator\n* Psychiatric or physical comorbidities (e.g., severe neurological or cardiovascular conditions) considered likely to interfere with participation or study results, at the discretion of the Principal Investigator","ALL","18 Years",{"count":124,"type":125},594,"ESTIMATED","INTERVENTIONAL",[128],"NA","Mood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor symptoms in psychiatric patients. The EC-102 randomized controlled trial will evaluate its impact compared to usual care on symptoms, quality of life, healthcare costs, comorbidities, and user adherence and satisfaction.",[131],"Mood Disorder (Depressive Episodes)","2026-04-27",{"date":134,"type":135},"2026-05-01","ACTUAL",{"date":137,"type":135},"2025-10-31",{"date":139,"type":125},"2027-12-01",{"name":5,"class":6},6]